Skyward Specialty to Host First Quarter 2024 Earnings Call Thursday, May 2, 2024
HOUSTON, April 08, 2024 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc.™ (NASDAQ: SKWD) ("Skyward Specialty" or "the Company") expects to...
HOUSTON, April 08, 2024 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc.™ (NASDAQ: SKWD) ("Skyward Specialty" or "the Company") expects to...
Cash position now expected to fund current operating plan into 2026 Financing provides cash runway to advance the ongoing pivotal...
NEW YORK, April 8, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics...
Fort Lee, NJ, April 08, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) today recapped poster highlights from the...
RADNOR, Pa., April 8, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company,...
Cost saving initiatives aimed at reducing operating and investing cash flows by approximately $170 million over the next 12 months...
NEW YORK, April 8, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics...
MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today...
Captisol-enabled™ Topiramate Injection shown to be a substitute for an oral dose on a one-to-one basis Contacts Investors: Michael Jeong...
DENVER, Colo., Apr 08, 2024 (247marketnews.com)- Auddia Inc. (NASDAQ:AUUD) reported that it was awarded U.S. Patent 11,935,520, from the U.S....
JERUSALEM, April 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the...
ROCKAWAY, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today...
The public can submit nominations for the nationwide contest now through June 14. Contacts Michelle Goret, Cintas Vice President of...
BERKELEY HEIGHTS, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic...
Additional 4-HNE (4-hydroxynonenal) biomarker data to highlight the correlation of bulbar and limb onset ALS (Amyotrophic Lateral Sclerosis) to 4-HNE...
– In preclinical studies, CHS-1000 shows a high affinity for human ILT4, reverses ILT4-mediated immunosuppressive functions, leading to activation of...
Contacts Investor Contact Shane Xie investors@confluent.io Media Contact Taylor Jones pr@confluent.io Confluent, Inc. (NASDAQ: CFLT), the data streaming pioneer, today...
Contacts Infineon Technologies, AG Andre Tauber Head of Media Relations +49 89 234 23888 andre.tauber@infineon.com Amkor Technology, Inc. Jennifer Jue...
The “Better Way” campaign to showcase how the Invisalign Palatal Expander System is a more positive patient experience and is...
Contacts For further information: Dennis Hancock President and Chief Executive Officer Mountain Valley MD Holdings Inc. Investor Relations @ 647-725-9755...
Vancouver, B.C., April 08, 2024 (GLOBE NEWSWIRE) -- Trillion Energy International Inc. (“Trillion” or the “Company”) (CSE: TCF) (OTCQB: TRLEF)...
Contacts BlackRock TCP Capital Corp. Katie McGlynn 310-566-1094 investor.relations@tcpcapital.com BlackRock TCP Capital Corp. (NASDAQ: TCPC) announced today that it will...
Savara’s Partner, Trillium Health LLC, to Present Data on the Laboratory Blood Test for Diagnosing aPAP Company to Host Industry...
Contacts Sam Sova Partner and CEO SOVA Sam@letsgosova.com Soluna Holdings, Inc. (“SHI” or the “Company”), (NASDAQ: SLNH), a developer of...
Built in India, the First Sub-meter Resolution Optical Satellite Reaches Orbit Contacts Media Relations: Tata Advanced Systems Limited Sarika Kapoor...
Prospective, multi-center Trifecta-Heart and DTRT-2 studies demonstrate excellent performance of the Prospera Heart test for detecting rejection in adults and...
Contacts Investor Relations: Brian Norris Senior Vice President of Finance and Investor Relations +1.781.374.8082 bnorris@evolvtechnology.com Evolv Technology (NASDAQ: EVLV), the...
Contacts Investor Relations: Erica Smith CyberArk 617-558-2132 ir@cyberark.com Media: Nick Bowman CyberArk +44 (0) 7841 673378 press@cyberark.com CyberArk (NASDAQ: CYBR),...
Ron Shvili and Sarit Sagiv bring decades of strategic technology and finance expertise Contacts Investor Relations Contact: Dean Ridlon Cognyte...
WATERTOWN, Mass., April 08, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to...
ASML reports transactions under its current share buyback programVELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions,...
DENVER, Colo., Apr 08, 2024 (247marketnews.com)- Brera Holdings PLC (NASDAQ:BREA), MicroStrategy (NASDAQ:MSTR), Manchester United (NYSE:MANU), Goldman Sachs (NYSE:GS), and JP...
DUBLIN, Ireland and BRIDGEWATER, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today highlighted three data presentations...
ROCKVILLE, Md., April 08, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...
- 12-Month Net Sales Reached ~$19.7 million, Gain of ~31% for FY2024 ended Feb 29, 2024-- Q4 Net Sales Grew...
Launching in more than 1,000 Stores! Contacts For investors, investors@yerbae.com or 480.471.8391 To reach CEO Todd Gibson, todd@yerbae.com or 480.471.8391...
Lakewood, Colo., April 08, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today...
As part of a larger company initiative to increase supply chain resiliency, this initiative will focus on specialized 40nm processes...
DENVER, April 8, 2024 /PRNewswire/ -- Landsea Homes Corporation (Nasdaq: LSEA) ("Landsea Homes" or the "Company"), a publicly traded residential...
SOUTH SAN FRANCISCO, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose –...